Immutep Reports Positive TACTI-002 Data
19 February 2020 SYDNEY, AUSTRALIA – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, announces interim data from its ongoing Phase II TACTI-002 study.…
Message from the Chair of BioMelbourne Network
18 February 2020 The Board of BioMelbourne Network advises members and stakeholders that our Chief Executive Officer, Dr Julie-Anne White, has given notice of her resignation. Julie will assist in the transition and hand-over to an interim CEO,…
Test measures immune response to improve ovarian cancer diagnosis
17 February 2020 Researchers have developed a simple blood test that measures the body’s own immune response to improve diagnosis of ovarian cancer. Ovarian cancer is one of the most common gynaecologic cancers, with the highest mortality rate. About…
SAHMRI and Trajan Nutrition sign new agreement to accelerate nutrition testing worldwide
17 February 2020 Adelaide, South Australia Trajan Nutrition has signed a Memorandum of Understanding with the South Australian Health and Medical Research Institute (SAHMRI) to accelerate the translation in the global market of nutrition testing research led by…
Erectile Dysfunction a Potential Target for Exopharm’s Exosomes
14 February 2020 An Australian-developed regenerative therapy is exploring the possibility of a treatment for Erectile dysfunction (ED) through stimulating the regenerative and healing capacities of the body. Exopharm Limited (ASX: EX1) has been testing its exosomes –…
The 3-D printed healthcare revolution
12 February 2020 By Michelle Wheeler, freelance science journalist, for Particle Need brain surgery? We’ll get printing now. Imagine you need a complicated and risky operation to insert an implant into your brain. The implant has been custom…
New Australian technology to treat lung disease
12 February 2020 Australian Associated Press Diagnosing lung disease will now be faster and more accurate, thanks to new non-invasive technology developed at Monash University. The technology will enable doctors to check if treatments for respiratory illnesses are…
Taskforce To Help Shape Victoria’s Innovation Agenda
13 February 2020 Taskforce To Help Shape Victoria’s Innovation Agenda Minister for Jobs, Innovation and Trade The Andrews Labor Government is bolstering Victoria’s position as a leading destination for tech and innovation by bringing together startups, universities, businesses…
Australia’s biotech innovations heading offshore, prompting calls for greater funding to bring them to market
13 February 2020 From ABC News By business reporter Rachel Pupazzoni The demand on the health sector has never been more evident, as the world scrambles to come up with a treatment for coronavirus. More than 1,000 people have…
Government fails in bid to block Senate inquiry
11 February 2020 The enabling legislation for proposed changes to the R&D Tax Incentive ha officially been referred to a Senate inquiry. The government failed in a bid to block the inquiry. Labor combined with the Greens and…
Under-the-radar BRII program surfaces
11 February 2020 James Riley, Editorial Director The Industry department’s Business Research and Innovation Initiative has been on a slow burn since it was announced as part of the National Innovation and Science Agenda in December 2015. The Challenge-based…
Patients with challenging cancers to benefit from genomic sequencing
12 February 2020 More than 1000 Victorian cancer patients are set to benefit from real-time genomic testing in the next three years, aiming to improve diagnosis and provide more targeted and effective treatments for cancers of unmet need.…
